The biological clock as an ally in the fight against inflammatory disease

January 29, 2018, ANRS

What if the symptoms and seriousness of certain inflammatory diseases were linked to time of day? Researchers from Inserm, Institut Pasteur de Lille and Université de Lille have been working on this hypothesis, after noting that the seriousness and mortality associated with fulminant hepatitis were dependent on the time at which the disease was induced. Their study, conducted on human cells and mice, shows that the anti-inflammatory action of a biological clock protein could prevent the onset of fulminant hepatitis by alleviating symptoms and increasing survival rates.

This research has been published in Gastroenterology.

Fulminant hepatitis is a serious disease that leads to rapid deterioration of tissue and liver function associated with blood coagulation disorders and irreparable brain damage. Overdose with medications containing acetaminophen is among the most common causes of the disease. Accumulation of acetaminophen in the body can cause cellular stress, which gives rise to an abnormal immune system response. This is expressed by excessive inflammation, which destroys hepatocytes and the liver. Until now, no specific treatment for fulminant hepatitis has been identified, and the only solution is liver transplant within 24 hours following onset of symptoms. Researchers from Inserm, Institut Pasteur de Lille and Université de Lille are focusing on the mechanisms underlying inflammation specifically in fulminant hepatitis, with a view to identifying potential avenues of treatment.

Starting from the observation that immune functions vary during the day, the researchers examined a biological clock protein called Rev-erbα and its potential role in regulating inflammation in fulminant hepatitis. This protein notably targets adipose tissue, together with liver, skeletal muscle and brain cells. It plays a major role in developing and regulating the circadian rhythm, i.e. the repetition of the biological cycle every 24 hours.

This new research, conducted on human immune system cells and on mice, showed that the inflammation also follows a circadian rhythm. The researchers observed that injecting a molecule potentiating the action of Rev-erbα reduced the inflammatory response causing hepatocyte death in fulminant hepatitis. Mice having received the Rev-erbα-activating treatment demonstrated less severe forms of the disease, and had a higher survival rate. As the same results were observed in vitro on , these data indicate new avenues to be explored with a view to potentially developing a treatment for acute fulminant hepatitis, and slowing the progression of symptoms in patients awaiting transplantation.

Fulminant is not the only disease involving the circadian molecular mechanism inhibited by Rev-erbα. Other diseases such as peritonitis, diabetes or even atherosclerosis display a similar imbalance in the due to the abnormal accumulation of toxins in the body. Inserm researcher Hélène Duez says, "The results of this study could open up new prospects in preventing these diseases. They also offer new avenues for researchers, notably in terms of potential improvements in quality of life and longevity among patients suffering from ."

Explore further: Cellular mechanism for severe viral hepatitis identified

More information: B. Pourcet et al, Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity Of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice, Gastroenterology (2017). DOI: 10.1053/j.gastro.2017.12.019

Related Stories

Cellular mechanism for severe viral hepatitis identified

January 18, 2018
KAIST medical scientists identified a cellular mechanism causing inflammatory changes in regulatory T cells that can lead to severe viral hepatitis. Research on this mechanism will help further understand the nature of various ...

Effect of gut bacteria on specific immune cells underlies persistent liver inflammation

January 16, 2018
Persistent liver inflammation in sufferers of chronic viral hepatitis is likely caused by interactions between pro-inflammatory immune cells in the liver and products from gut bacteria, according to new work involving A*STAR ...

Hepatitis therapy: Kupffer cells adjust the balance between pathogen control and hepatocyte regenera

January 17, 2018
Inflammation of the liver can result from different causes. Besides infections with hepatitis B virus (HBV) and hepatitis C virus (HCV), other viruses such as cytomegalovirus (CMV) are able to trigger acute hepatitis. Sometimes ...

Role of transcriptional co-factor hints at possible inflammatory bowel disease treatment

December 12, 2017
Inflammatory bowel disease (IBD), including the two conditions ulcerative colitis and Crohn's disease, results in long-term inflammation of the gut and is associated with dysregulation of the immune system. However, it is ...

New model for hepatitis B helps identify potential new therapeutic approach

October 26, 2015
A promising new avenue for treating hepatitis B has been reported by researchers at Hiroshima University who have developed a new animal model of the disease.

Recommended for you

Chance discovery links inflammatory bowel disease with common bacterial gut toxin

May 17, 2018
New research has uncovered a surprise link between a common bacterial toxin found in the gut and inflammatory bowel disease (IBD).

New cytokine network can repair tissue damage in the intestine, study finds

May 16, 2018
A new group of proteins called cytokines, critical for antimicrobial activity and repairing the damaged intestinal tissue found in inflammatory bowel disease (IBD), has been discovered by researchers in a study led by Georgia ...

International study suggests alternative treatment for mild asthma

May 16, 2018
A large international study led by a Hamilton researcher has found a patient-centric treatment that works for people with mild asthma.

Study shows yogurt may dampen chronic inflammation linked to multiple diseases

May 14, 2018
Inflammation can be good. It's part of the body's innate immune system, our first line of defense against illness and injury.

New study provides insight into blood signatures of inflammation

May 8, 2018
A new study from Boston University Schools of Medicine (BUSM) and Public Health (BUSPH) identifies a pattern of inflammation associated with cardio-metabolic risks among participants in the Black Women's Health Study, as ...

Metabolites shed by intestinal microbiota keep inflammation at bay

May 4, 2018
Researchers at Tufts University have elucidated a mechanism by which the "good" bacteria that reside in our gastrointestinal tract can help protect us from inflammation, and how their disruption (dysbiosis) can increase the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.